000 | 01994 a2200541 4500 | ||
---|---|---|---|
005 | 20250515173251.0 | ||
264 | 0 | _c20090623 | |
008 | 200906s 0 0 eng d | ||
022 | _a1572-0241 | ||
024 | 7 |
_a10.1038/ajg.2009.83 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aScherl, Ellen J | |
245 | 0 | 0 |
_aSafety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study. _h[electronic resource] |
260 |
_bThe American journal of gastroenterology _cJun 2009 |
||
300 |
_a1452-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
650 | 0 | 4 |
_aColitis, Ulcerative _xcomplications |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGastrointestinal Hemorrhage _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMesalamine _xadministration & dosage |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPhenylhydrazines _xadministration & dosage |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRectum |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aSigmoidoscopy |
650 | 0 | 4 | _aTablets |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aPruitt, Ronald | |
700 | 1 | _aGordon, Glenn L | |
700 | 1 | _aLamet, Mark | |
700 | 1 | _aShaw, Audrey | |
700 | 1 | _aHuang, Shirley | |
700 | 1 | _aMareya, Shadreck | |
700 | 1 | _aForbes, William P | |
773 | 0 |
_tThe American journal of gastroenterology _gvol. 104 _gno. 6 _gp. 1452-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/ajg.2009.83 _zAvailable from publisher's website |
999 |
_c18916378 _d18916378 |